© 2020 MJH Life Sciences and OncLive. All rights reserved.
November 26, 2019
Edward A. Stadtmauer, MD, discusses what makes BCMA a unique target in multiple myeloma.
October 29, 2019
Edward A. Stadtmauer, MD, section chief, Hematologic Malignancies, and Roseman, Tart, Harrow, and Shaffer Families’ President’s Distinguished Professor, Penn Medicine, University of Pennsylvania, discusses promising targets in multiple myeloma.
October 04, 2019
Edward A. Stadtmauer, MD, discusses the use of selinexor in patients with heavily pretreated, relapsed/refractory multiple myeloma.
November 03, 2017